Newsletter Subject

FDA Panel Favors Dropping OTC Decongestant

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Sep 12, 2023 10:52 PM

Email Preheader Text

Daily Headlines Tuesday, September 12, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLI

[MEDPAGE TODAY]( Daily Headlines Tuesday, September 12, 2023 Today's Top Stories for {NAME} [PUBLIC HEALTH & POLICY]( [FDA Panel Favors Dropping OTC Decongestant]( [INFECTIOUS DISEASE]( [CDC Advisors Support Updated COVID Shots for All]( [NEUROLOGY]( [Dementia Risk Tied to Sedentary Lifestyle]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [New and Emerging Immunotherapeutic Approaches to Advanced Melanoma]( [MEETING COVERAGE]( [Smart Inhaler for Asthma Misses the Mark for Boosting Adherence to Meds]( [PUBLIC HEALTH & POLICY]( [DEA Gets an Earful About Telehealth Prescribing of Controlled Substances]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [PUBLIC HEALTH & POLICY]( [Med Students Also Plagued by High Insurance Costs for Mental Health]( CME SPOTLIGHT [COVID-19 Prevention for Immunocompromised Individuals]( [PHARMACY]( [CancelRx System Reduced Drug Dispensing on Discontinued Scripts]( [MEETING COVERAGE]( [Study Questions Use of Aggressive Surgery in Early Mesothelioma]( [NEUROLOGY]( [Telomeres and Dementia; Cell Therapy and Parkinson's; Next Up: In Utero Neurology]( CME SPOTLIGHT [Improving Patient-Centered Treatment and Management of PNH]( [CARDIOLOGY]( [Upfront Ezetimibe in ACS; New Watchman LAA Occluder OK'd; Low-Cost FH Genotyping]( [MEETING COVERAGE]( [Adding First-Line Chemo Boosts PFS in EGFR-Mutant Lung Cancer]( [RHEUMATOLOGY]( [Here's Another Racial-Ethnic Disparity in Back Pain Care]( CME SPOTLIGHT [Emerging Evidence in the Treatment of Chronic Lymphocytic Leukemia]( [NEUROLOGY]( [Is Intracerebral Hemorrhage Risk Shared via Blood Transfusion?]( [OPINION]( [This Isn't COVID's Final Act]( [CARDIOLOGY]( [Afib Catheter Ablation Wins Points for Psych Improvement]( CME SPOTLIGHT [Uncovering the Underlying Cause of Anemia: Making a Myelodysplastic Syndrome Diagnosis]( [CARDIOLOGY]( [Novel System Snags FDA Approval for Severe Peripheral Arterial Disease]( [MEETING COVERAGE]( [PCPs Often First Stop for Managing Newly Diagnosed Depression]( [OPINION]( [Should You Get the Flu Shot and COVID Booster at the Same Time?]( CME SPOTLIGHT [Evidence-Based Strategies for Integrating CAR T-Cell Therapy Into Non-Hodgkin Lymphoma Care]( [SPECIAL REPORTS]( [Rural Hospital Turns to GoFundMe to Stay Afloat]( [MEDICAL JOURNEYS]( [Antiretroviral Therapy for HIV: When Less May Be More]( [MEDICAL JOURNEYS]( [For Your Patients: The ABCs of HIV Medication]( [MEETING COVERAGE]( [Safety Profile Sways Physicians on Use of LAIs for Schizophrenia]( [ASCO READING ROOM]( [Susan Parsons, MD, on Inconsistent Use of PET-Adapted Approaches in Hodgkin Lymphoma]( # Weekly Survey [Should Older Docs Be Put Out to Pasture?]( Healthcare consultant Ron Harman King weighed in this week on the debate over [whether physicians should be legally forced to retire]( at a certain age like some other professions[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-09-12&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.